Age | Pregnancy | Breast Feeding
Item
the patient (male or non-pregnant/non lactating female1) must be > 18 years of age.
boolean
C0001779 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Informed Consent | Informed Consent Patient Representative
Item
the patient or legally authorized representative must sign a written informed consent, prior to the procedure.
boolean
C0021430 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C0030701 (UMLS CUI [2,2])
Deep Vein Thrombosis High risk of | Orthopedic Surgical Procedure Status post | Anticoagulation Therapy | Warfarin | Standard Follow-Up Care | INR test
Item
the potentially eligible patient is at high (post-orthopedic surgery) risk of dvt and the treatment plan will include anticoagulation using warfarin with standard of care follow up including inr assessment.
boolean
C0149871 (UMLS CUI [1,1])
C0332167 (UMLS CUI [1,2])
C1136201 (UMLS CUI [2,1])
C0231290 (UMLS CUI [2,2])
C0003281 (UMLS CUI [3])
C0043031 (UMLS CUI [4])
C3897505 (UMLS CUI [5])
C0851084 (UMLS CUI [6])
Deep Vein Thrombosis | Deep Vein Thrombosis High risk of | Orthopedic Surgical Procedure Status post | Anticoagulation Therapy | Warfarin | Standard Follow-Up Care | INR test
Item
the potentially eligible patient is diagnosed with dvt or at high (post-orthopedic surgery) risk of dvt and the treatment plan will include anticoagulation using warfarin with standard of care follow up including inr assessment.
boolean
C0149871 (UMLS CUI [1])
C0149871 (UMLS CUI [2,1])
C0332167 (UMLS CUI [2,2])
C1136201 (UMLS CUI [3,1])
C0231290 (UMLS CUI [3,2])
C0003281 (UMLS CUI [4])
C0043031 (UMLS CUI [5])
C3897505 (UMLS CUI [6])
C0851084 (UMLS CUI [7])
Atrial Fibrillation | Anticoagulation Therapy | Warfarin | Standard Follow-Up Care | INR test
Item
patient is diagnosed with atrial fibrillation (af) and the treatment plan will include anticoagulation using warfarin with standard of care follow up including inr assessment.
boolean
C0004238 (UMLS CUI [1])
C0003281 (UMLS CUI [2])
C0043031 (UMLS CUI [3])
C3897505 (UMLS CUI [4])
C0851084 (UMLS CUI [5])
Heart failure Sinus rhythm | Cardiac ejection fraction | Akinesia Apical | Left ventricular aneurysm | Cardiac wall motion Abnormality Extensive | Warfarin | Thromboembolism Risk Reducing
Item
heart failure patients (ef<25% or apical akinesis or left ventricular aneurysm or extensive wall motion abnormality) in sinus rhythm being started on warfarin to reduce the risk of thromboembolism.
boolean
C0018801 (UMLS CUI [1,1])
C0232201 (UMLS CUI [1,2])
C0232174 (UMLS CUI [2])
C0085623 (UMLS CUI [3,1])
C0205111 (UMLS CUI [3,2])
C0519097 (UMLS CUI [4])
C0232167 (UMLS CUI [5,1])
C1704258 (UMLS CUI [5,2])
C0205231 (UMLS CUI [5,3])
C0043031 (UMLS CUI [6])
C0040038 (UMLS CUI [7,1])
C0035647 (UMLS CUI [7,2])
C0392756 (UMLS CUI [7,3])
Childbearing Potential Contraceptive methods
Item
women of childbearing potential must be using adequate measures of contraception (as determined by the investigator) to avoid pregnancy and should be highly unlikely to conceive during the study period.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Childbearing Potential Pregnancy test negative
Item
women of childbearing potential must have a negative pregnancy test at screen.
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Unacceptable
Item
pregnant and/or lactating women and women of child bearing potential not using acceptable means of contraception.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C1883420 (UMLS CUI [3,3])
Study Subject Participation Status | Investigational New Drugs | marketed products
Item
participation in any other clinical trials involving investigational or marketed products within 30 days prior to entry in the study.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C0683746 (UMLS CUI [3])